Notwithstanding the nursing home misjudgment, NY flatted

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks Shady #40403
391
Notwithstanding the nursing home misjudgment, NY flatted the curve of Covid19 cases and deaths, the red states preferred to learn the hard way. AOC is the right's wet dream, she's not on the ticket as far as the people described below are concerned. She's far from the whipping boy that McConnell and Barr are/will be.

In Poll, Trump Falls Far Behind Biden in Six Key Battleground States

Dwindling white support for the president leads to a deficit of at least six points in each state.


By Nate Cohn

June 25, 2020

NYT Upshot/
Siena College poll

Joe Biden holds a strong lead among registered voters in six battleground states carried by Donald Trump in 2016.

2016 Result NYT/Siena June 2020

Michigan (n=610) <1 Trump +11 Biden
47-36

Wisconsin (655) <1 Trump +11 Biden
49-38

Pennsylvania (651) <1 Trump +10 Biden
50-40

Florida (651) +1 Trump +6 Biden
47-41

Arizona (650) +4 Trump +7 Biden
48-41

North Carolina (653) +4 Trump +9 Biden
49-40

President Trump has lost significant ground in the six battleground states that clinched his Electoral College victory in 2016, according to New York Times/Siena College surveys, with Joseph R. Biden Jr. opening double-digit leads in Michigan, Pennsylvania and Wisconsin.

Mr. Trump’s once-commanding advantage among white voters has nearly vanished, a development that would all but preclude the president’s re-election if it persisted. Mr. Biden now has a 21-point lead among white college graduates, and the president is losing among white voters in the three Northern battleground states — not by much, but he won them by nearly 10 points in 2016.

Four years ago, Mr. Trump’s strength in the disproportionately white working-class battleground states allowed him to win the Electoral College while losing the popular vote. The surveys indicate that the president continues to fare better in these relatively white battleground states than he does nationwide.

A separate Times/Siena survey released on Wednesday found Mr. Biden leading by 14 points nationwide, 50 percent to 36 percent.


Mr. Biden would win the presidency with at least 333 electoral votes, far more than the 270 needed, if he won all six of the states surveyed and held those won by Hillary Clinton four years ago. Most combinations of any three of the six states — which also include Florida, Arizona and North Carolina — would suffice.

With a little more than four months to go until the election, there is still time for the president’s political standing to recover, just as it did on so many occasions four years ago. He maintains a substantial advantage on the economy, which could become an even more central issue in what has already been a volatile election cycle. And many of the undecided voters in these states lean Republican, and may end up returning to their party’s nominee.

But for now, the findings confirm that the president’s political standing has deteriorated sharply since October, when Times/Siena polls found Mr. Biden ahead by just two percentage points across the same six states (the average gap is now nine points). Since then, the nation has faced a series of crises that would pose a grave political challenge to any president seeking re-election. The polls suggest that battleground-state voters believe the president has struggled to meet the moment.

Over all, 42 percent of voters in the battleground states approve of how Mr. Trump is handling his job as president, while 54 percent disapprove.

These six​ states — with their mix of major cities, old industrial hubs, growing suburbs, and even farmland — together deliver a grim judgment of Mr. Trump on recent issues that have shaken American life. His handling of the pandemic and the protests after the death of George Floyd help explain his erosion across both old and new battlegrounds.


https://www.nytimes.com/2020/06/25/upshot/pol...e9f650852d

Allan Larson, 83, a recently retired mechanical engineer in Apache Junction, Ariz., began to regret his vote for the president shortly after he took office — he said Mr. Trump tried to do away with too many things President Obama had done, and kept firing good people — but his handling of the pandemic solidified his views.

“He’s not doing anything about this here virus,” said Mr. Larson, who plans to vote for Mr. Biden. “Just the way he’s running things, I don’t think he’s doing the job he should do.”

On these recent issues, voter disapproval reflects more than just general dissatisfaction with the state of the country. It seems to reflect deeper disagreement with the president’s prioritization of the economy over stopping the spread of coronavirus, and with his focus on law and order over criminal justice.

A majority of voters, 63 percent, say they would rather back a presidential candidate who focuses on the cause of protests, even when the protests go too far, while just 31 percent say they would prefer to support a candidate who says we need to be tough on demonstrations that go too far.


Despite double-digit unemployment, 55 percent of voters in these six states say the federal government’s priority should be to limit the spread of the coronavirus, even if it hurts the economy, while just 35 percent say the federal government’s priority should be to restart the economy. Even the newly unemployed, who would seem to have the most to gain from a reopened economy, say stopping the coronavirus should be the government’s priority.

A high-profile clash with Gov. Gretchen Whitmer of Michigan encapsulates the president’s challenge. Mr. Trump sided with protesters who opposed her stay-at-home orders, but voters in the state oppose the protests against social distancing restrictions by 57 percent to 37 percent.

As of now, 59 percent of voters in Michigan disapprove of Mr. Trump’s handling of the coronavirus, the highest level of disapproval in any battleground state polled. And nearly 40 percent of registered voters there, including 11 percent of Republicans, say he has treated their state worse than others in response to the pandemic.

Mr. Trump retains the support of 86 percent of respondents who said they voted for him in 2016, down from 92 percent in October.

Mr. Biden, by contrast, has emerged from a contested primary with a unified Democratic coalition. He wins 93 percent of the voters who backed Mrs. Clinton four years ago, as well as 92 percent of self-identified Democrats. Mr. Biden also enjoys a significant advantage among those who voted for neither Mr. Trump nor Mrs. Clinton in 2016. He has a 35-point lead among battleground voters who said they backed a minor-party candidate or wrote in another.

Together, these shifts give Mr. Biden a six-point lead among voters who participated in the 2016 election, according to voter-file records. The same voters said they backed Mr. Trump over Mrs. Clinton in 2016 by 2.5 percentage points, slightly better for Mr. Trump than the actual result of the six states, offering a level of validity to the survey’s findings. Mr. Biden also has a 17-point lead among registered voters who did not vote in the 2016 race.

Mr. Trump’s edge among white voters has dwindled despite national attention to the kind of racial issues that many analysts believed propelled his strength among white voters in the first place. If attitudes about race were vital to Mr. Trump’s appeal with white voters, then a foundation of his strength has been badly shaken.


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading